홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

(1S)-2-{4-[2-(6-amino-8-bromo-9H-purin-9-yl)ethyl]piperidin-1-yl}-1-methyl-2-oxoethyl acetate → (1S)-2-[4-(2-{6-Amino-8-[(7-chloro-1,3-benzothiazol-2-yl)thio]-9H-purin-9-yl}ethyl)piperidin-1-yl]-1-methyl-2-oxoethyl acetate

HRID 445099
인쇄

반응식

HRID 445099 반응식
[C:1]([O:4][C@@H:5]([CH3:27])[C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][CH2:15][N:16]2[C:24](Br)=[N:23][C:22]3[C:17]2=[N:18][CH:19]=[N:20][C:21]=3[NH2:26])[CH2:10][CH2:9]1)=[O:7])(=[O:3])[CH3:2].[Cl:28][C:29]1[C:37]2[S:36][C:35]([SH:38])=[N:34][C:33]=2[CH:32]=[CH:31][CH:30]=1>>[C:1]([O:4][C@@H:5]([CH3:27])[C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][CH2:15][N:16]2[C:24]([S:38][C:35]3[S:36][C:37]4[C:29]([Cl:28])=[CH:30][CH:31]=[CH:32][C:33]=4[N:34]=3)=[N:23][C:22]3[C:17]2=[N:18][CH:19]=[N:20][C:21]=3[NH2:26])[CH2:10][CH2:9]1)=[O:7])(=[O:3])[CH3:2]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 57850528(1S)-2-{4-[2-(6-amino-8-bromo-9H-purin-9-yl)ethyl]piperidin-1-yl}-1-methyl-2-oxoethyl acetateHCID 1785277847-Chloro-2-mercaptobenzothiazole

생성물 1

HCID 57850093(1S)-2-[4-(2-{6-Amino-8-[(7-chloro-1,3-benzothiazol-2-yl)thio]-9H-purin-9-yl}ethyl)piperidin-1-yl]-1-methyl-2-oxoethyl acetate

실험 절차

The title product was prepared according to the procedure described for example 81 using (1S)-2-{4-[2-(6-amino-8-bromo-9H-purin-9-yl)ethyl]piperidin-1-yl}-1-methyl-2-oxoethyl acetate and 7-chloro-2-mercaptobenzothiazole. LC-MS [M+H]+ 562.1, along with hydrolyzed product, the mixture was used for the next step without any further purification.

후처리

  1. customLC-MS [M+H]+ 562.1, along with hydrolyzed product, the mixture was used for the next step without any further purification

출처 및 근거

ORD 기록
ord-943e279f59c949ff8614cdf9b830d59f
출처 데이터셋
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08476285B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트